0001209191-22-012156.txt : 20220223 0001209191-22-012156.hdr.sgml : 20220223 20220223160548 ACCESSION NUMBER: 0001209191-22-012156 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220211 FILED AS OF DATE: 20220223 DATE AS OF CHANGE: 20220223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Blouse Grant E. CENTRAL INDEX KEY: 0001869883 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51173 FILM NUMBER: 22663480 MAIL ADDRESS: STREET 1: C/O CATALYST BIOSCIENCES, INC. STREET 2: 611 GATEWAY BOULEVARD, SUITE 710 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001124105 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562020050 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 611 GATEWAY BLVD., SUITE 710 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-871-0761 MAIL ADDRESS: STREET 1: 611 GATEWAY BLVD., SUITE 710 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: TARGACEPT INC DATE OF NAME CHANGE: 20000919 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-11 0 0001124105 CATALYST BIOSCIENCES, INC. CBIO 0001869883 Blouse Grant E. C/O CATALYST BIOSCIENCES, INC. 611 GATEWAY BOULEVARD, SUITE 710 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Scientific Officer Stock Option (Right to Buy) 0.52 2022-02-11 4 A 0 200000 0.00 A 2032-02-11 Common Stock 200000 200000 D 1/4 of the shares subject to the option will vest on the one-year anniversary of the vesting commencement date of February 11, 2022, and 1/48 of the shares subject to the option will vest on each monthly anniversary of the vesting commencement date thereafter. /s/ Seline Miller, Attorney-in-Fact for Grant E. Blouse 2022-02-23